Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Orquest seeks European marketing clearance for Healos

Oct. 19, 1998

Amgen expands calcimimetic drug development

Oct. 19, 1998

Alliance decisively moves ahead with development of blood substitute

Oct. 19, 1998

Hemosol successfully completes U.K. Hemolink trial

Oct. 16, 1998

New treatment option now available for type II diabetics in the U.K.

Oct. 16, 1998

Phase I trials to begin with vomeropherin compound for PMS

Oct. 15, 1998

Pharming and Genzyme form joint venture to develop enzyme for Pompe's disease

Oct. 15, 1998

U.K. launch announced for Evista

Oct. 15, 1998

Japanese laboratory synthesizes new antidiabetic agents

Oct. 15, 1998

Another market introduction for Novartis bisphosphonate

Oct. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...